New Health Options Act of 2025
HB1776, the “New Health Options Act of 2025,” would amend the Affordable Care Act and related federal health laws to create a temporary federal reinsurance program for certain individual-market off-exchange health plans. The program would be administered by the Secretary of Health and Human Services and would make payments to insurers for high-cost claims for eligible enrollees, with funding capped at $6 billion per year from 2026 through 2030. The stated purpose is to lower premiums for individuals enrolled in covered plans.
The bill also creates a mechanism for insurers to opt certain individual-market plans out of the ACA single risk pool rules, while preserving the 3-to-1 age-rating limit for qualified health plans. For opt-out plans, the bill would relax age-based premium variation rules to allow more actuarially justified pricing for adults, and it would require federal agencies to treat those plans as eligible for integration with individual health reimbursement arrangements. In addition, the bill would require group and individual plans to let certain out-of-network cost-sharing count toward deductibles and out-of-pocket maximums when the provider’s charge is at or below specified benchmarks, and it would require providers and facilities to disclose when a patient’s cost-sharing exceeds the cash price for the same service.
The bill’s impact on state and federal law would be significant primarily through federal health insurance regulation. It would amend the Public Health Service Act and the Affordable Care Act, affecting insurer rating rules, risk pooling, reinsurance funding, deductible and out-of-pocket calculations, and price-disclosure obligations. It would also create a private right of action for patients harmed by a provider’s failure to disclose lower prices, with damages tied to the law of the state where the provider is located, while leaving implementation details to HHS and other federal agencies.
The available context shows no committee debate, recorded votes, or formal opposition/support statements, so there is no documented sentiment from proceedings. Based on the bill’s structure, the general policy intent appears pro-consumer and pro-premium-reduction, but it also gives insurers more flexibility outside the qualified health plan framework. Because the bill has only been referred to committee, its political reception cannot yet be measured from the provided record.
Notable points of contention likely include the opt-out from the single risk pool, the relaxation of age-rating limits for certain plans, and the size and structure of the federal reinsurance subsidy. Consumer advocates may focus on whether the bill truly lowers premiums and improves transparency, while critics may question whether it could fragment the individual market or weaken ACA protections for some plans. Providers and insurers may also disagree over the new disclosure and cost-sharing rules, especially the private enforcement provision and the requirement to apply certain out-of-network costs to in-network accumulators.
The bill would amend multiple federal health statutes, chiefly the Affordable Care Act and the Public Health Service Act, to create a federally funded reinsurance program, alter individual-market rating and risk-pooling rules for certain plans, and impose new cost-sharing and price-disclosure requirements. It would affect health insurers, health plans, health care providers, and patients in the individual and group markets, with implementation beginning in 2026 for most provisions and HHS given authority to set program parameters.
No committee transcripts or votes are provided, so there is no recorded legislative sentiment in the available materials. The bill’s text suggests a generally favorable posture toward lowering premiums and increasing price transparency, but it also includes market-structure changes that could draw mixed reactions from insurers, providers, and ACA-focused stakeholders.
The main likely points of contention are the creation of a large federal reinsurance subsidy, the ability of some individual-market plans to opt out of the single risk pool, and the bill’s partial relaxation of age-based premium limits for those plans. Another likely dispute is the new requirement that certain out-of-network charges count toward deductibles and out-of-pocket maximums, along with the private right of action for patients when providers fail to disclose lower prices. Supporters would likely emphasize premium relief and transparency, while opponents may argue the bill could weaken ACA market protections or increase administrative and compliance burdens.